Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06119308 · ClinicalTrials.gov registry record · NA
Brief Cognitive Behavioral Therapy to Enhance Benzodiazepine Deprescribing
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT06119308 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 17 participants.
The verdict
NCT06119308, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to conduct a single-arm pilot trial of a brief cognitive-behavioral therapy-enhanced benzodiazepine deprescribing intervention in 20 older adults (aged ≥55 years) prescribed chronic benzodiazepines by their primary care clinicians.
Interventions
- OTHER Benzodiazepine Medication Taper with Cognitive Behavioral Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2023-11-08 |
| Est. Completion | 2025-06-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06119308
The ClinicalTrials.gov registry entry for NCT06119308 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Benzodiazepine Medication Taper with Cognitive Behavioral Therapy is the first listed.
NCT06119308 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06119308 about?
NCT06119308 is a clinical study titled "Brief Cognitive Behavioral Therapy to Enhance Benzodiazepine Deprescribing". The goal of this clinical trial is to conduct a single-arm pilot trial of a brief cognitive-behavioral therapy-enhanced benzodiazepine deprescribing intervention in 20 older adults (aged ≥55 years) prescribed chronic benzodiazepines by their primary care clinicians.
What is the current status of trial NCT06119308?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2023-11-08. Estimated completion is 2025-06-08.
What interventions are being tested in trial NCT06119308?
The interventions under investigation include: Benzodiazepine Medication Taper with Cognitive Behavioral Therapy (OTHER).
Who is sponsoring clinical trial NCT06119308?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.